Status:
UNKNOWN
TAP Blocks vs. IV Lidocaine for Kidney Transplants
Lead Sponsor:
Benaroya Research Institute
Conditions:
Postoperative Pain
Eligibility:
All Genders
18+ years
Phase:
PHASE2
PHASE3
Brief Summary
This study will compare continuous intravenous lidocaine against single-injection transversus abdominis plane (TAP) block as a modality for postoperative analgesia in kidney transplant surgery.
Detailed Description
This study is a non-inferiority trial designed to assess the analgesic efficacy of an intravenous (IV) lidocaine infusion against single-injection transversus abdominis plane (TAP) block in patients u...
Eligibility Criteria
Inclusion
- Kidney transplant recipient
- \>18 years old
- Consent to participate
Exclusion
- \<18 years old
- Refusal to participate
- Chronic opioid use
- Seizure disorder
- Allergy to local anesthestics
- Severe hepatic disease
Key Trial Info
Start Date :
April 1 2019
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
September 1 2021
Estimated Enrollment :
124 Patients enrolled
Trial Details
Trial ID
NCT03843879
Start Date
April 1 2019
End Date
September 1 2021
Last Update
July 17 2019
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Virginia Mason Medical Center
Seattle, Washington, United States, 98101